AIG
NKTR icon

American International Group’s Nektar Therapeutics NKTR Stock Holding History

American International Group’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-6,632
Closed -$69.9K – 3136
2023
Q1 		$69.9K Buy
6,632
+26
+0.4% +$787 ﹤0.01% 2612
2022
Q4 		$224K Sell
6,606
-50
-0.8% -$2.42K ﹤0.01% 2079
2022
Q3 		$319K Buy
6,656
+78
+1% +$4.64K ﹤0.01% 1857
2022
Q2 		$375K Buy
6,578
+5,513
+518% +$348K ﹤0.01% 1794
2022
Q1 		$86K Sell
1,065
-6
-0.6% -$888 ﹤0.01% 2648
2021
Q4 		$217K Sell
1,071
-20,027
-95% -$4.34M ﹤0.01% 2320
2021
Q3 		$5.68M Sell
21,098
-489
-2% -$118K 0.03% 747
2021
Q2 		$5.56K Sell
21,587
-416
-2% -$115K 0.02% 810
2021
Q1 		$6.6K Buy
22,003
+428
+2% +$133K 0.02% 723
2020
Q4 		$5.5K Sell
21,575
-281
-1% -$72.6K 0.02% 741
2020
Q3 		$5.44M Sell
21,856
-310
-1% -$97.5K 0.03% 622
2020
Q2 		$7.7M Sell
22,166
-707
-3% -$221K 0.04% 461
2020
Q1 		$6.12M Sell
22,873
-771
-3% -$238K 0.03% 486
2019
Q4 		$7.66M Buy
23,644
+18,619
+371% +$5.4M 0.03% 578
2019
Q3 		$1.37M Buy
5,025
+1
+0% +$367 0.01% 1139
2019
Q2 		$2.68M Buy
5,024
+268
+6% +$134K 0.01% 905
2019
Q1 		$2.4M Sell
4,756
-9
-0.2% -$5.33K 0.01% 942
2018
Q4 		$2.35M Buy
4,765
+727
+18% +$439K 0.01% 925
2018
Q3 		$3.69M Buy
4,038
+469
+13% +$400K 0.01% 869
2018
Q2 		$2.61M Sell
3,569
-6,163
-63% -$7.11M 0.01% 921
2018
Q1 		$15.5M Buy
9,732
+1,800
+23% +$2.32M 0.05% 203
2017
Q4 		$7.11M Buy
7,932
+41
+0.5% +$24.3K 0.02% 602
2017
Q3 		$2.84M Buy
7,891
+432
+6% +$135K 0.01% 881
2017
Q2 		$2.19M Buy
7,459
+1,719
+30% +$497K 0.01% 940
2017
Q1 		$2.02M Sell
5,740
-833
-13% -$187K 0.01% 937
2016
Q4 		$1.21M Buy
6,573
+73
+1% +$14.8K ﹤0.01% 1139
2016
Q3 		$1.68M Hold
6,500
– – 0.01% 975
2016
Q2 		$1.39M Sell
6,500
-293
-4% -$65.5K 0.01% 1021
2016
Q1 		$1.4M Buy
6,793
+313
+5% +$60.1K 0.01% 1283
2015
Q4 		$1.64M Buy
6,480
+78
+1% +$16K 0.01% 1213
2015
Q3 		$1.05M Buy
6,402
+38
+0.6% +$6.72K ﹤0.01% 1424
2015
Q2 		$1.19M Buy
6,364
+937
+17% +$161K ﹤0.01% 1451
2015
Q1 		$895K Sell
5,427
-134
-2% -$27.5K ﹤0.01% 1700
2014
Q4 		$1.29M Sell
5,561
-210
-4% -$44.9K 0.01% 1375
2014
Q3 		$1.04M Sell
5,771
-3,226
-36% -$617K ﹤0.01% 1547
2014
Q2 		$1.73M Buy
8,997
+3,160
+54% +$559K 0.01% 1215
2014
Q1 		$1.06M Buy
5,837
+580
+11% +$115K 0.01% 1479
2013
Q4 		$895K Sell
5,257
-38
-0.7% -$6.13K ﹤0.01% 1551
2013
Q3 		$830K Buy
5,295
+32
+0.6% +$5.92K ﹤0.01% 1553
2013
Q2 		$912K Buy
+5,263
New +$807K 0.01% 1433

Other funds holding NKTR

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

American International Group's NKTR Position: Q2 2023 in Review

American International Group sold out of Nektar Therapeutics (NKTR) in Q2 2023, closing a stake of 6,632 shares — an estimated $69.9K sold.

American International Group first reported a position in NKTR in Q2 2013 and held it in 40 quarters. The position peaked at $15.5M in Q1 2018. 146 funds tracked by Wall St. Rank hold NKTR as of Q2 2023.

  • American International Group reported no remaining Nektar Therapeutics position as of Q2 2023 after selling out during the quarter.
  • American International Group sold 6,632 Nektar Therapeutics shares in Q2 2023, an estimated $69.9K.
  • American International Group first reported a position in Nektar Therapeutics in Q2 2013 and held it in 40 quarters.
  • American International Group's Nektar Therapeutics position peaked at $15.5M in Q1 2018.
  • 146 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2023.

Based on American International Group's 13F filing for Q2 2023, filed 4 Aug 2023.